0001751294-19-000001.txt : 20190716 0001751294-19-000001.hdr.sgml : 20190716 20190715192855 ACCESSION NUMBER: 0001751294-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190716 DATE AS OF CHANGE: 20190715 EFFECTIVENESS DATE: 20190716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cure, Inc. CENTRAL INDEX KEY: 0001751294 IRS NUMBER: 371867828 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344374 FILM NUMBER: 19956029 BUSINESS ADDRESS: STREET 1: 10 BARCLAY STREET #31G CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: 301-785-5255 MAIL ADDRESS: STREET 1: 10 BARCLAY STREET #31G CITY: NEW YORK STATE: NY ZIP: 10007 D 1 primary_doc.xml X0708 D LIVE 0001751294 Cure, Inc. 225 Fifth Avenue #2D NEW YORK NY NEW YORK 10010 000-000-0000 DELAWARE None None Corporation true 2017 Lauren Picasso 225 Fifth Avenue #2D New York NY NEW YORK 10010 Executive Officer Director Other Decline to Disclose 06b false 2019-07-01 false true true false 0 1000000 25000 975000 false 1 0 0 0 true The proceeds will be used for general working capital, which may include payments to persons listed in in Item 3. false Cure, Inc. /s/ Lauren Picasso Lauren Picasso President and CEO 2019-07-15